The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin. [electronic resource]
Producer: 20080507Description: 7191-8 p. digitalISSN:- 1078-0432
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Biphenyl Compounds -- administration & dosage
- Carboplatin -- administration & dosage
- Cell Line, Tumor
- Drug Administration Schedule
- Drug Synergism
- Female
- Humans
- Mice
- Nitrophenols -- administration & dosage
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- administration & dosage
- Piperazines -- administration & dosage
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- RNA Interference
- RNA, Small Interfering -- genetics
- Sulfonamides -- administration & dosage
- Xenograft Model Antitumor Assays
- bcl-X Protein -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.